Jennifer Miller, PhD, is president of Bioethics International and an Assistant Professor at NYU School of Medicine. She and colleagues created a Good Pharma Scorecard to rank new drugs and their manufacturers on the transparency of clinical trial information for those new drugs. There were some disturbing findings from their initial analysis, which she explains in this podcast. See more detail in our broader blog post at http://www.healthnewsreview.org/?p=42604.